Andreas Goette

37.6k total citations · 6 hit papers
198 papers, 8.6k citations indexed

About

Andreas Goette is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Andreas Goette has authored 198 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Cardiology and Cardiovascular Medicine, 18 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Andreas Goette's work include Atrial Fibrillation Management and Outcomes (135 papers), Cardiac Arrhythmias and Treatments (103 papers) and Cardiac electrophysiology and arrhythmias (63 papers). Andreas Goette is often cited by papers focused on Atrial Fibrillation Management and Outcomes (135 papers), Cardiac Arrhythmias and Treatments (103 papers) and Cardiac electrophysiology and arrhythmias (63 papers). Andreas Goette collaborates with scholars based in Germany, United Kingdom and United States. Andreas Goette's co-authors include Paulus Kirchhof, Uwe Lendeckel, Helmut Klein, Ulrich Schotten, Sander Verheule, Clegg Honeycutt, Jonathan J. Langberg, Christof Huth, J. Christoph Geller and Christoph Röcken and has published in prestigious journals such as The Lancet, Circulation and Physiological Reviews.

In The Last Decade

Andreas Goette

179 papers receiving 8.4k citations

Hit Papers

Pathophysiological Mechanisms of Atrial Fibrillation: A T... 2011 2026 2016 2021 2011 2014 2019 2021 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal
    2011 891 citations Ulrich Schotten, Sander Verheule et al. profile →
  2. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
    2014 473 citations Thorsten Lewalter, Andreas Goette et al. profile →
  3. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
    2019 383 citations Pascal Vranckx, Lars Eckardt et al. profile →
  4. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
    2021 141 citations Andreas Rillig, Christina Magnussen et al. Circulation profile →
  5. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
    2023 100 citations William F. McIntyre, Alexander P. Benz et al. Circulation profile →
  6. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
    2023 79 citations Gregory Y.H. Lip, Marco Proietti et al. EP Europace profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Goette Germany 45 7.5k 1.1k 648 572 499 198 8.6k
Shih-Ann Chen Taiwan 45 5.6k 0.7× 967 0.9× 430 0.7× 289 0.5× 264 0.5× 200 6.4k
Jianzeng Dong China 35 3.6k 0.5× 713 0.7× 681 1.1× 280 0.5× 365 0.7× 442 5.5k
Isabelle C. Van Gelder Netherlands 56 12.4k 1.7× 650 0.6× 838 1.3× 525 0.9× 659 1.3× 239 13.2k
Masaharu Akao Japan 41 3.5k 0.5× 1.8k 1.7× 465 0.7× 576 1.0× 316 0.6× 231 5.7k
Dawood Darbar United States 44 5.7k 0.8× 1.5k 1.4× 679 1.0× 133 0.2× 348 0.7× 171 6.7k
Paolo Golino Italy 43 3.9k 0.5× 1.1k 1.0× 1.6k 2.4× 705 1.2× 719 1.4× 265 7.5k
Lino Gonçalves Portugal 28 3.4k 0.5× 848 0.8× 1.4k 2.1× 235 0.4× 1.1k 2.3× 321 5.1k
Ken Okumura Japan 45 4.5k 0.6× 1.2k 1.1× 1.2k 1.8× 518 0.9× 1.4k 2.9× 268 7.4k
Antonio Hernández‐Madrid Spain 29 6.7k 0.9× 678 0.6× 864 1.3× 107 0.2× 405 0.8× 158 7.2k
Patrick Henry France 30 2.1k 0.3× 490 0.5× 1.2k 1.9× 309 0.5× 408 0.8× 131 3.9k

Countries citing papers authored by Andreas Goette

Since Specialization
Citations

This map shows the geographic impact of Andreas Goette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Goette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Goette more than expected).

Fields of papers citing papers by Andreas Goette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Goette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Goette. The network helps show where Andreas Goette may publish in the future.

Co-authorship network of co-authors of Andreas Goette

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Goette. A scholar is included among the top collaborators of Andreas Goette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Goette. Andreas Goette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Duncker, David, Christine Alonso, Mauro Biffi, et al.. (2025). Expected Benefits From Antibacterial Envelope in Different CIED Patient Populations. Pacing and Clinical Electrophysiology. 48(11). 1274–1280. 1 indexed citations
3.
Merino, José Luís, Juan Tamargo, Carina Blomström‐Lundqvist, et al.. (2025). Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. EP Europace. 27(8). 10 indexed citations
4.
Fengsrud, Espen, Carina Blomström‐Lundqvist, A. John Camm, et al.. (2025). Antiarrhythmic drug use in atrial fibrillation among different European countries – as determined by a physician survey. IJC Heart & Vasculature. 59. 101709–101709.
5.
Rillig, Andreas, Lars Eckardt, Katrin Borof, et al.. (2024). Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial. EP Europace. 26(6). 14 indexed citations
6.
7.
Schotten, Ulrich, Andreas Goette, & Sander Verheule. (2024). Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches. Nature Reviews Cardiology. 22(4). 225–240. 7 indexed citations
8.
Tjong, Fleur V.Y., Laura Perrotta, Andreas Goette, et al.. (2024). Utilization of and perceived need for simulators in clinical electrophysiology: results from an EHRA physician survey. EP Europace. 26(2). 5 indexed citations
9.
McIntyre, William F., Alexander P. Benz, Nina Becher, et al.. (2023). Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation. 149(13). 981–988. 100 indexed citations breakdown →
10.
Lip, Gregory Y.H., Marco Proietti, Tatjana Potpara, et al.. (2023). Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. EP Europace. 25(9). 79 indexed citations breakdown →
11.
Ahmed, Fozia, Carina Blomström‐Lundqvist, Heather L. Bloom, et al.. (2021). Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score. EP Europace. 23(9). 1446–1455. 25 indexed citations
12.
Capodanno, Davide, Marco Di Maio, Antonio Greco, et al.. (2020). Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 9(16). e017212–e017212. 56 indexed citations
13.
Bertaglia, Emanuele, Benjamin Blank, Carina Blomström‐Lundqvist, et al.. (2019). Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. EP Europace. 21(10). 1459–1467. 44 indexed citations
14.
Thomas, Dierk, Torsten Christ, Larissa Fabritz, et al.. (2018). German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management. Clinical Research in Cardiology. 108(6). 577–599. 26 indexed citations
15.
16.
Lehmann, H. Immo, Carmen Wolke, Friedrich‐Wilhelm Röhl, et al.. (2012). Enzymatic activity of DPIV and renin–angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). International Journal of Cardiology. 168(1). 255–260. 4 indexed citations
17.
Goette, Andreas, Alicja Bukowska, Uwe Lendeckel, et al.. (2008). Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression. Circulation. 117(6). 732–742. 89 indexed citations
18.
Schild, Lorenz, Alicja Bukowska, Andreas Gardemann, et al.. (2006). Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism—A model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(6). 608–615. 31 indexed citations
19.
20.
Goette, Andreas, Clegg Honeycutt, & Jonathan J. Langberg. (1996). Electrical remodeling is mediated by intracellular calcium overload. Journal of the American College of Cardiology. 27(2). 23–23.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shih-Ann Chen Breakdown of academic impact, for papers by Jianzeng Dong Breakdown of academic impact, for papers by Isabelle C. Van Gelder Breakdown of academic impact, for papers by Masaharu Akao Breakdown of academic impact, for papers by Dawood Darbar Breakdown of academic impact, for papers by Paolo Golino Breakdown of academic impact, for papers by Lino Gonçalves Breakdown of academic impact, for papers by Ken Okumura Breakdown of academic impact, for papers by Antonio Hernández‐Madrid Breakdown of academic impact, for papers by Patrick Henry
Rankless by CCL
2026